Cargando…

Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

BACKGROUND: Bladder cancer (BLCA) is a malignant tumor with a dismay outcome. Increasing evidence has confirmed that chromatin regulators (CRs) are involved in cancer progression. Therefore, we aimed to explore the function and prognostic value of CRs in BLCA patients. METHODS: Chromatin regulators...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ke, Liu, Xiaoqiang, Deng, Wen, Wang, Gongxian, Fu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819906/ https://www.ncbi.nlm.nih.gov/pubmed/35125116 http://dx.doi.org/10.1186/s41065-021-00212-x

Ejemplares similares

Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer
por: Xu, Yan, et al.
Publicado: (2023)

CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells
por: Liu, Xiaoqiang, et al.
Publicado: (2019)

A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients
por: Liu, Zesi, et al.
Publicado: (2022)

Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis
por: Liu, Xiaoqiang, et al.
Publicado: (2020)

Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis
por: Liu, Xiaoqiang, et al.
Publicado: (2020)

Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer
por: Li, Sheng, et al.
Publicado: (2023)

Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma
por: Li, Junwu, et al.
Publicado: (2022)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

Impact of pathological T3a upstaging on oncological outcomes of clinical T1 renal cell carcinoma: a meta-analysis
por: Chen, Luyao, et al.
Publicado: (2019)

TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
por: Zhou, Zhengtao, et al.
Publicado: (2020)

Prognostic significance of bladder neck involvement in non‐muscle‐invasive bladder cancer: A SEER database analysis with 19,919 patients
por: Zhan, Xiangpeng, et al.
Publicado: (2021)

Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis
por: Liu, Xiaoqiang, et al.
Publicado: (2019)

Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis
por: Liu, Xiaoqiang, et al.
Publicado: (2023)

Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
por: Shen, Chong, et al.
Publicado: (2022)

The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma
por: Deng, Wen, et al.
Publicado: (2021)

Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma
por: Zhang, PeiPei, et al.
Publicado: (2021)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Identification of circular RNA signature in bladder cancer
por: Yang, Xiao, et al.
Publicado: (2017)

Overexpression of F-box and WD repeat domain containing 7 prevents tumor growth of bladder cancer cells through regulating SREBP1a
por: Liu, Fang, et al.
Publicado: (2022)

Identification of key candidate genes and biological pathways in bladder cancer
por: Gao, Xin, et al.
Publicado: (2018)

Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses
por: Shu, Jun, et al.
Publicado: (2022)

Bioinformatics-based analysis of potential candidates chromatin regulators for immune infiltration in osteoarthritis
por: Wang, Weiwei, et al.
Publicado: (2022)

The chromatin signatures of enhancers and their dynamic regulation
por: Barral, Amandine, et al.
Publicado: (2023)

Independent Factors Affecting Postoperative Short-Term Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy
por: Deng, Wen, et al.
Publicado: (2021)

Robot‐assisted versus laparoscopic partial nephrectomy for anatomically complex T1b renal tumors with a RENAL nephrometry score ≥7: A propensity score‐based analysis
por: Deng, Wen, et al.
Publicado: (2019)

Identification of Parkinson’s disease-associated chromatin regulators
por: Xing, Hailong, et al.
Publicado: (2023)

Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer
por: Nie, Jianqiang, et al.
Publicado: (2023)

Chromatin signatures of cancer
por: Morgan, Marc A., et al.
Publicado: (2015)

An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer
por: Lian, Penghu, et al.
Publicado: (2019)

Functional and Oncological Outcomes Following Robot-Assisted and Laparoscopic Radical Prostatectomy for Localized Prostate Cancer With a Large Prostate Volume: A Retrospective Analysis With Minimum 2-Year Follow-Ups
por: Deng, Wen, et al.
Publicado: (2021)

Transvesical Versus Posterior Approach to Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Retrospective Comparison With a 12-Month Follow-Up
por: Deng, Wen, et al.
Publicado: (2021)

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer
por: Ma, Hangbin, et al.
Publicado: (2023)

Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed
por: Mekonnen, Yonatan Ayalew, et al.
Publicado: (2019)

Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer
por: Song, Yuxuan, et al.
Publicado: (2020)

Pharmacological Interventions for Bacterial Prostatitis
por: Xiong, Situ, et al.
Publicado: (2020)

Transvesical Retzius-Sparing Versus Standard Robot-Assisted Radical Prostatectomy: A Retrospective Propensity Score-Adjusted Analysis
por: Deng, Wen, et al.
Publicado: (2021)

A prognosis prediction chromatin regulator signature for patients with severe asthma
por: Gao, Yaning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bjdd832105fcfc5k3fbf4nf72e